Cited by 388Intramuscular injections and effectsAdvanced Drug Delivery SystemsLymphatic System and Diseases

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Effect of Molecular Weight on the Lymphatic Absorption of Water-Soluble Compounds Following Subcutaneous Administration

Supersaxo, Andreas, Hein, Wayne R., Steffen, Hans·1990·Pharmaceutical Research

DOI 10.1023/a:1015880819328

Open this paper in CoChat — free account

Abstract

The lymphatic absorption of four water-soluble compounds with different molecular weights (MW) was determined by measuring their cumulative recovery in lymph draining from the site of s.c. administration in sheep. The cumulative recoveries (% of dose, mean +/- SD; N = 3) were 4.0 +/- 1.5 (5-fluoro-2'-deoxyuridine, MW 246.2), 21.0 +/- 7.1 (inulin, MW 5200), 38.6 +/- 6.7 (cytochrome c, MW 12,300), and 59.5 +/- 7.7 [human recombinant interferon (rIFN) alpha-2a, MW 19,000], respectively. Our data show that in the investigated MW range, there is a linear relationship between the molecular weight and the proportion of the dose absorbed lymphatically. An increase in molecular weight results in an increased lymphatic absorption. Molecules with MW greater than 16,000 are absorbed mainly by the lymphatics which drain the application site. The knowledge gained in this investigation may help to improve the mode of administration and therapeutic efficacy of endogenous proteins whose targets are lymphoid cells (e.g., interferons, interleukins). Practical implications for the clinical use of such proteins are discussed.

Integrity signals

Registry

Crossref · 10.1023/a:1015880819328

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The human interferons—From protein purification and sequence to cloning and expression in bacteria: Before, between, and beyond
Pestka, S. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90118-2 · Cited by 236
THE OUTPUT OF CELLS IN LYMPH FROM THE POPLITEAL NODE OF SHEEP
Hall, J. G., & Morris, B. (1962) · Quarterly Journal of Experimental Physiology and Cognate Medical Sciences · doi:10.1113/expphysiol.1962.sp001620 · Cited by 227
Theory and practice of site-specific drug delivery
Tomlinson, E. (1987) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(87)90001-9 · Cited by 148
STUDIES ON THE PERMEABILITY OF LYMPHATIC CAPILLARIES
Leak, L. V. (1971) · The Journal of Cell Biology · doi:10.1083/jcb.50.2.300 · Cited by 147
The physiological interferon response
Bocci, V. A. (1985) · Immunology Today · doi:10.1016/0167-5699(85)90159-8 · Cited by 77
Roles of interferon produced in physiological conditions. A speculative review.
Bocci, V. A. (1988) · PubMed Central · Cited by 75
Recombinant Human Interferon Alpha-2a: Delivery to Lymphoid Tissue by Selected Modes of Application
Supersaxo, A., Hein, W., Gallati, H., & Steffen, H. (1988) · Pharmaceutical Research · doi:10.1023/a:1015957022073 · Cited by 46
Self-citation
Monoclonal antitumor antibodies in the lymphatics.
Weinstein, J. N., Steller, M. A., Covell, D. G., Holton, O. D., Keenan, A. M., Sieber, S. M., & Parker, R. (1984) · PubMed · Cited by 40
THE PERMEABILITY OF THE CAPILLARIES OF THE DOG TO PROTEIN
Field, M. E., & Drinker, C. K. (1931) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1931.97.1.40 · Cited by 37
Sheep as an Experimental Model for Immunology: Immunological Techniques in Vitro and in Vivo
Miyasaka, M., & Trnka, Z. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-442703-7.50030-9 · Cited by 36

Show all 14 references

Research works printed but not linked: 5

J. N. Weinstein, M. A. Steller, D. G. Covell, O. D. Holton, A. M. Keenan, S. M. Sieber, and R. J. Parker. Cancer Treat. Rep. 68:257–264 (1984).
H. Gallati. J. Clin. Chem. Clin. Biochem. 22:907–914 (1982).
C. C. C. O'Morchoe and P. J. O'Morchoe. Lymphology 20:205–209 (1987).
G. Poste. Proc. Int. Symp. Control. Rel. Bioact. Mater. 15:1–2 (1988).
V. Bocci. Immunology 64:1–9 (1988).

Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
Wang, W., Wang, E., & Balthasar, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.170 · Cited by 978
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
Dirks, N. L., & Meibohm, B. (2010) · Clinical Pharmacokinetics · doi:10.2165/11535960-000000000-00000 · Cited by 500
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
Strohl, W. R. (2015) · BioDrugs · doi:10.1007/s40259-015-0133-6 · Cited by 461
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
Bittner, B., Richter, W., & Schmidt, J. (2018) · BioDrugs · doi:10.1007/s40259-018-0295-0 · Cited by 447
Beyond antigens and adjuvants: formulating future vaccines
Moyer, T. J., Zmolek, A. C., & Irvine, D. J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81083 · Cited by 374
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
Richter, W. F., Bhansali, S. G., & Morris, M. E. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9367-0 · Cited by 377
Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration
Frost, G. I. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.427 · Cited by 323
Pharmacokinetic aspects of biotechnology products
Tang, L., Persky, A. M., Hochhaus, G., & Meibohm, B. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20125 · Cited by 303
A recombinant human enzyme for enhanced interstitial transport of therapeutics
Bookbinder, L. H., Hofer, A., Haller, M. F., Zepeda, M. L., Keller, G.-A., Lim, J. E., Edgington, T. S., Shepard, H. M., Patton, J. S., & Frost, G. I. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.027 · Cited by 282
Modeling the human skin barrier — Towards a better understanding of dermal absorption
Jepps, O. G., Dancik, Y., Anissimov, Y. G., & Roberts, M. S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.003 · Cited by 266
Physical Stability of Nonviral Plasmid‐Based Therapeutics
Anchordoquy, T. J., & Koe, G. S. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200003)89:3<297::aid-jps2>3.0.co;2-p · Cited by 91
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Pant, S., Wainberg, Z. A., Weekes, C. D., Furqan, M., Kasi, P. M., Devoe, C. E., Leal, A. D., Chung, V., Basturk, O., VanWyk, H., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02760-3 · Cited by 267
Barriers to rehabilitation following surgery for primary breast cancer
Cheville, A. L., & Tchou, J. C. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20782 · Cited by 260
Subcutaneous drug delivery and the role of the lymphatics
McLennan, D. N., Porter, C. J. H., & Charman, S. A. (2005) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2005.05.006 · Cited by 259
Controlling timing and location in vaccines
Irvine, D. J., Aung, A., & Silva, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.019 · Cited by 256
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
Yu, X. M., Dai, Y., Zhao, Y., Qi, S., Liu, L., Lu, L., Luo, Q., & Zhang, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-14906-9 · Cited by 253
Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges
Vugmeyster, Y. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i4.73 · Cited by 253
(D) Routes of delivery: Case studies
Patton, J. S., & Platz, R. M. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90002-8 · Cited by 251
Subcutaneous delivery of monoclonal antibodies: How do we get there?
Viola, M., Sequeira, J. A. D., Seiça, R. M. F., Veiga, F., Serra, J. P., Paiva‐Santos, A. C., & Ribeiro, A. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.001 · Cited by 249
Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
Dostálek, M., Gardner, I. B., Gurbaxani, B. M., Rose, R. H., & Chetty, M. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0027-4 · Cited by 236
Subcutaneous Absorption of Biotherapeutics: Knowns and Unknowns
Richter, W. F., & Jacobsen, B. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059238 · Cited by 235
Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems
Glassman, P. M., & Muzykantov, V. R. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257113 · Cited by 223
Lymphedema: Anatomy, Physiology and Pathogenesis
Szuba, A., & Rockson, S. G. (1997) · Vascular Medicine · doi:10.1177/1358863x9700200408 · Cited by 213
Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies: Concepts and Lessons for Drug Development
Mould, D. R., & Green, B. (2010) · BioDrugs · doi:10.2165/11530560-000000000-00000 · Cited by 212
Supramolecular PEGylation of biopharmaceuticals
Webber, M. J., Appel, E. A., Vinciguerra, B., Cortinas, A. B., Thapa, L. S., Jhunjhunwala, S., Isaacs, L., Langer, R., & Anderson, D. G. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616639113 · Cited by 208
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs
Crommelin, D. J. A., Storm, G., Verrijk, R., de Leede, L., Jiskoot, W., & Hennink, W. E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00376-4 · Cited by 201
The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution
Nakamura, T., Kawai, M., Sato, Y., Maeki, M., Tokeshi, M., & Harashima, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01182 · Cited by 193
Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery
Rao, D. A., Forrest, M. L., Alani, A. W. G., Kwon, G. S., & Robinson, J. R. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21970 · Cited by 190
Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics
Hawley, A. E., Davis, S. S., & Illum, L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00045-9 · Cited by 183
Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins
Turner, M. R., & Balu‐Iyer, S. V. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.01.007 · Cited by 179
Review of Polyclonal Antibody Production Procedures in Mammals and Poultry
Hanly, W. C., Artwohl, J. E., & Bennett, B. T. (1995) · ILAR Journal · doi:10.1093/ilar.37.3.93 · Cited by 177
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
Yang, B., & Kido, A. (2011) · Clinical Pharmacokinetics · doi:10.2165/11586040-000000000-00000 · Cited by 168
Overview of Antibody Drug Delivery
Awwad, S., & Angkawinitwong, U. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030083 · Cited by 160
Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
Mahmood, I., & Green, M. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544040-00001 · Cited by 150
Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure
Dancik, Y., Miller, M. A., Jaworska, J., & Kasting, G. B. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.006 · Cited by 150
Targeting the lymphatics using dendritic polymers (dendrimers)
Kaminskas, L. M., & Porter, C. J. H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.016 · Cited by 133
Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration
Howard, G. P., Verma, G., Ke, X., Thayer, W. M., Hamerly, T., Baxter, V. K., Lee, J. E., Dinglasan, R. R., & Mao, H. (2019) · Nano Research · doi:10.1007/s12274-019-2301-3 · Cited by 133
Fate of Water‐Soluble Polymers Administered via Different Routes
Yamaoka, T., Tabata, Y., & Ikada, Y. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840316 · Cited by 130
A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components
Kinnunen, H. M., Sharma, V. K., Contreras-Rojas, L. R., Yu, Y., Alleman, C., Sreedhara, A., Fischer, S., Khawli, L. A., Yohe, S. T., Bumbaca, D., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.016 · Cited by 128
The Antibody Drug Absorption Following Subcutaneous or Intramuscular Administration and Its Mathematical Description by Coupling Physiologically Based Absorption Process with the Conventional Compartment Pharmacokinetic Model
Zhao, L. Y., Ji, P., Li, Z., Roy, P., & Sahajwalla, C. G. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.4 · Cited by 128
Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2‐Positive Breast Cancer
Wynne, C., Harvey, V. J., Schwabe, C., Waaka, D., McIntyre, C., & Bittner, B. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270012436560 · Cited by 127
Lymphatic transport of proteins after s.c. injection: implications of animal model selection
Porter, C. J. H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00153-3 · Cited by 123
Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
Abdallah, M., Müllertz, O. O., Styles, I. K., Mörsdorf, A., Quinn, J. F., Whittaker, M. R., & Trevaskis, N. L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.046 · Cited by 119
Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges
Maisel, K., Sasso, M. S., Potin, L., & Swartz, M. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.005 · Cited by 115
Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics
Collins, D. S., Sánchez-Félix, M., Badkar, A. V., & Mrsny, R. J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.036 · Cited by 115
Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy
Qin, L., Zhang, H., Zhou, Y., Umeshappa, C. S., & Gao, H. (2021) · Small · doi:10.1002/smll.202006000 · Cited by 114
A Bottom-Up Whole-Body Physiologically Based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins
Gill, K. L., Gardner, I. B., Li, L., & Jamei, M. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9819-4 · Cited by 109
Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins
Jarvi, N. L., & Balu‐Iyer, S. V. (2021) · BioDrugs · doi:10.1007/s40259-020-00465-4 · Cited by 109
Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145565 · Cited by 107
Understanding Inter-Individual Variability in Monoclonal Antibody Disposition
Thomas, V. A., & Balthasar, J. P. (2019) · Antibodies · doi:10.3390/antib8040056 · Cited by 106
Challenges and Opportunities of Functionalized Cucurbiturils for Biomedical Applications
Yin, H., Cheng, Q., Bardelang, D., & Wang, R. (2023) · JACS Au · doi:10.1021/jacsau.3c00273 · Cited by 99
Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects
Xu, Z., Wang, Q., Zhuang, Y., Frederick, B., Yan, H., Bouman‐Thio, E., Marini, J. C., Keen, M., Snead, D., Davis, H. M., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009340782 · Cited by 97
Proposed pathway and mechanism of vascularized lymph node flaps
Ito, R., Zelken, J. A., Yang, C., Lin, C., & Cheng, M. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.01.007 · Cited by 96
The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat model
Kagan, L., Gershkovich, P., Mendelman, A., Amsili, S., Ezov, N., & Hoffman, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.04.002 · Cited by 95
Pharmacokinetic Modeling of the Subcutaneous Absorption of Therapeutic Proteins
Kagan, L. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059121 · Cited by 94
Perspectives on Subcutaneous Route of Administration as an Immunogenicity Risk Factor for Therapeutic Proteins
Hamuro, L., Kijanka, G., Kinderman, F. S., Kropshofer, H., Bu, D., Zepeda, M. L., & Jawa, V. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.030 · Cited by 94
Ultrafast-Acting Insulins: State of the Art
Heinemann, L., & Muchmore, D. B. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600402 · Cited by 90
Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development
Glassman, P. M., & Balthasar, J. P. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.11.002 · Cited by 90
Tumescent Technique Chronicles
Klein, J. A. (1995) · Dermatologic Surgery · doi:10.1111/j.1524-4725.1995.tb00212.x · Cited by 90
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Dong, H., Li, Q., Zhang, Y., Ding, M., Teng, Z., & Mou, Y. (2023) · Advanced Science · doi:10.1002/advs.202301339 · Cited by 90
Lymphatic Transport and Catabolism of Therapeutic Proteins after Subcutaneous Administration to Rats and Dogs
Wang, W., Chen, N., Shen, X., Cunningham, P. K., Fauty, S. E., Michel, K. B., Wang, B., Hong, X., Adreani, C. M., Nunes, C. N., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.043604 · Cited by 86
Lymphatic system: a prospective area for advanced targeting of particulate drug carriers
Singh, I., Swami, R., Khan, W., & Sistla, R. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866088 · Cited by 83
Use of Alveolar Cell Monolayers of Varying Electrical Resistance to Measure Pulmonary Peptide Transport
Dodoo, A., Bansal, S. S., Barlow, D. J., Bennet, F., Hider, R. C., Lansley, A. B., Lawrence, M. J., & Marriott, C. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200002)89:2<199::aid-jps7>3.0.co;2-b · Cited by 18
Poloxamer-basedin situhydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats
Zhang, K., Shi, X., Lin, X., Yao, C., Shen, L., & Feng, Y. (2014) · Drug Delivery · doi:10.3109/10717544.2014.891272 · Cited by 81
Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Interferon-β1a in Monkeys
Mager, D. E., Neuteboom, B., Efthymiopoulos, C., Munafo, A., & Jusko, W. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049502 · Cited by 80
Subcutaneous Drug Delivery: A Route to Increased Safety, Patient Satisfaction, and Reduced Costs
Dychter, S. S., Gold, D. A., & Haller, M. F. (2012) · Journal of Infusion Nursing · doi:10.1097/nan.0b013e31824d2271 · Cited by 78
Dermal Clearance Model for Epidermal Bioavailability Calculations
Ibrahim, R. E., Nitsche, J. M., & Kasting, G. B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23106 · Cited by 78
Novel Delivery Systems for Improving the Clinical Use of Peptides
Kovalainen, M., Mönkäre, J., Riikonen, J., Pesonen, U., Vlasova, M. A., Salonen, J., Lehto, V., Järvinen, K., & Herzig, K. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008367 · Cited by 77
Drug Elimination Kinetics Following Subconjunctival Injection Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Kim, S. H., Csaky, K. G., Wang, N. S., & Lutz, R. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9408-z · Cited by 75
Pharmacokinetics and Leukocyte Responses of Recombinant Human Interleukin-10
Radwanski, E., Chakraborty, A., Wart, S. V., Huhn, R. D., Cutler, D. L., Affrime, M. B., & Jusko, W. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011918425629 · Cited by 73
Interspecies Comparisons of Pharmacokinetics and Pharmacodynamics of Recombinant Human Erythropoietin
Woo, S., & Jusko, W. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015248 · Cited by 72
Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease
Tamura, A., & Yui, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.016 · Cited by 70
Pharmacokinetic tuning of protein–antigen fusions enhances the immunogenicity of T-cell vaccines
Mehta, N. K., Pradhan, R., Soleimany, A. P., Moynihan, K. D., Rothschilds, A. M., Momin, N., Rakhra, K., Mata-Fink, J., Bhatia, S. N., Wittrup, K. D., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0563-4 · Cited by 68
Lymphatic Absorption of Subcutaneously Administered Proteins: Influence of Different Injection Sites on the Absorption of Darbepoetin Alfa Using a Sheep Model
Kota, J., Machavaram, K. K., McLennan, D. N., Edwards, G. A., Porter, C. J. H., & Charman, S. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015669 · Cited by 67
Engineering New Approaches to Cancer Vaccines
Mehta, N. K., Moynihan, K. D., & Irvine, D. J. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0112 · Cited by 66
Lymphatic Absorption Is a Significant Contributor to the Subcutaneous Bioavailability of Insulin in a Sheep Model
Charman, S. A., McLennan, D. N., Edwards, G. A., & Porter, C. J. H. (2001) · Pharmaceutical Research · doi:10.1023/a:1013046918190 · Cited by 66
Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery
Klepach, A., Tran, H., Mohammed, F. A., & ElSayed, M. E. H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114322 · Cited by 65
Subcutaneous drug delivery from nanoscale systems
Tomasini, L., Ferrere, M., & Nicolas, J. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00161-w · Cited by 65
Targeting Systemically Administered Proteins to Bone by Bisphosphonate Conjugation
Uludağ, H., & Yang, J. J. (2002) · Biotechnology Progress · doi:10.1021/bp0200447 · Cited by 64
Receptor-Mediated Pharmacokinetic/Pharmacodynamic Model of Interferon-β 1a in Humans
Mager, D. E., & Jusko, W. J. (2002) · Pharmaceutical Research · doi:10.1023/a:1020468902694 · Cited by 63
Fluorescence Imaging of the Lymph Node Uptake of Proteins in Mice after Subcutaneous Injection: Molecular Weight Dependence
Wu, F. P., Bhansali, S. G., Law, W., Bergey, E. J., Prasad, P. N., & Morris, M. E. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0708-6 · Cited by 61
The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant
de Veer, M., Kemp, J. M., Chatelier, J., Elhay, M. J., & Meeusen, E. N. T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.056 · Cited by 60
Electrostatic Interactions of Monoclonal Antibodies With Subcutaneous Tissue
Mach, H., Gregory, S., Mackiewicz, A. L., Mittal, S., Lalloo, A., Kirchmeier, M. J., & Shameem, M. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.31 · Cited by 60
Pharmacokinetic studies of protein drugs: Past, present and future
Ezan, É. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.03.007 · Cited by 59
Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery
Tang, Y., Liu, B., Zhang, Y., Liu, Y., Huang, Y., & Fan, W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115304 · Cited by 58
The Lymphatic System Plays a Major Role in the Intravenous and Subcutaneous Pharmacokinetics of Trastuzumab in Rats
Dahlberg, A. H., Kaminskas, L. M., Smith, A., Nicolazzo, J. A., Porter, C. J. H., Bulitta, J. B., & McIntosh, M. P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400464s · Cited by 58
Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine
Wei, L., Zhao, Y., Hu, X., & Tang, L. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01174 · Cited by 57
Injectables and Depots to Prolong Drug Action of Proteins and Peptides
Ibeanu, N., Egbu, R., Onyekuru, L., Javaheri, H., Khaw, P. T., Williams, G. R., Brocchini, S., & Awwad, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100999 · Cited by 57
Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep
McLennan, D. N., Porter, C. J. H., Edwards, G. A., Martin, S. W., Heatherington, A. C., & Charman, S. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078790 · Cited by 57
Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins
Zou, P., Wang, F., Wang, J., Lu, Y., Tran, D. C., & Seo, S. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.038 · Cited by 56
The lymphatic vasculature: An active and dynamic player in cancer progression
Rezzola, S., Sigmund, E. C., Halin, C., & Ronca, R. (2021) · Medicinal Research Reviews · doi:10.1002/med.21855 · Cited by 56
Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics
Shah, D. K. (2015) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-015-9447-8 · Cited by 56
Facilitated subcutaneous immunoglobulin (fSCIg) therapy – practical considerations
Ponsford, M., Carne, E. M., Kingdon, C., Joyce, C., Price, C. R., Williams, C., El‐Shanawany, T., Williams, P. E., & Jolles, S. R. A. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12694 · Cited by 53
Use of Recombinant Human Hyaluronidase to Accelerate Rapid Insulin Analogue Absorption: Experience with Subcutaneous Injection and Continuous Infusion
Vaughn, D. E., & Muchmore, D. B. (2011) · Endocrine Practice · doi:10.4158/ep11297.ra · Cited by 52
Recent advances in combination of microneedles and nanomedicines for lymphatic targeted drug delivery
Permana, A. D., Nainu, F., Moffatt, K., Larrañeta, E., & Donnelly, R. F. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1690 · Cited by 52
Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
Gurbaxani, B. M., Dostálek, M., & Gardner, I. B. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.008 · Cited by 51
Patient-centric design for peptide delivery: Trends in routes of administration and advancement in drug delivery technologies
Ganesh, A. N., Heusser, C., Garad, S., & Sánchez-Félix, M. V. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100079 · Cited by 49

Authors: Supersaxo, A., Hein, W. R., & Steffen, H.
Affiliations: F. Hoffmann-La Roche AG (CH)
ORCID: Hein, Wayne R.
Venue: Pharmaceutical Research
Publisher: Springer Science and Business Media LLC
Published: 1990-02
Volume: 7
Issue: 2
Pages: 167-169
ISSN: 0724-8741 (ISSN-L)
1573-904X
DOI: 10.1023/a:1015880819328
OpenAlex: W1586699825
Cited by: 386
References: 14
Citations by year: 2026: 12 · 2025: 17 · 2024: 25 · 2023: 20 · 2022: 25 · 2021: 29 · 2020: 21 · 2019: 19 · 2018: 18 · 2017: 9 · 2016: 11 · 2015: 20 · 2014: 10 · 2013: 20 · 2012: 25
FWCI: 5.21
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Pharmaceutical Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords: lymphatic absorption, molecular weight, subcutaneous administration, water-soluble compounds, lymphatic drainage, 5-fluorodeoxyuridine, inulin, cytochrome c, interferon alfa-2a, sheep, lymphatic drug delivery
MeSH terms: Absorption, Animals, Chemistry, Physical, Female, Floxuridine, Injections, Subcutaneous, Insulin, Interferon Type I, Lymphatic System, Male, Molecular Weight, Recombinant Proteins, Sheep, Solubility, Chemical Phenomena

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Effect of Molecular Weight on the Lymphatic Absorption of Water-Soluble Compounds Following Subcutaneous Administration

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks

Data sources